20
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids

, , , , , & show all
Pages 323-328 | Received 18 Oct 2001, Accepted 08 Apr 2002, Published online: 02 Jan 2014

References

  • Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticoster-oids. Arthritis Rheum 2000;43:1801–8.
  • Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271–92.
  • Hayashi Y, Kushida K, Kitazawa A, Tanizawa T, Hotokebuchi T, Hagino H, et al. Measurement of vertebral body dimensions of the thoracic and lumbar spines of 242 healthy women. J Bone Miner Metab 1998;16:27–33.
  • Hanson DA, Weis MA, Bonen A-M, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorp-tion: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251–8.
  • Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, et al. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560–6.
  • Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-EscofetD. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274–6.
  • Dhillon VB, Davies MC, Hall ML, Round JM, Ell PJ, Jacobs HS, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624–6.
  • Kalla AA, Fataar AB, Jessop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726–34.
  • Gilboe I-M, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: comparison with rheuma-toid arthritis and healthy controls. Ann Rheum Dis 2000;59:110–15.
  • Pons F, Penis P, Guanabens N, Font J, Huguet M, Espinosa G, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Ftheumatol 1995;34:742–6.
  • Kipen Y, Buchbinder R, Forbes A, Strauss B, Geoffrey L, MorandE. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Ftheumatol 1997;24:1922–9.
  • Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhelli D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Ftheumatol 1999;26:1280–4.
  • Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Ftheumatol 1998;37:405–10.
  • Sugimoto T, Tsutumi M, Fuji Y, Kawatsu M, Kegishi H, Lee MC, et al. Comparison of bone mineral content among Japanese, Koreans, and Taiwanese assessed by dual-photon absorptiometry. J Bone Miner Res 1992;7:153–9
  • Ferrari S, Ftizzoli R, Bonjour JP. Genetic aspects of osteoporosis. Curr Opin Ftheumatol 1999;11:294–300.
  • Lakshminarayanan S, Walsh S, Mohanraj M, Rothefield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Ftheumatol 2001;28:102–8.
  • Kyd PA, Vooght KD, Kerkhoff F, Thomas E, Fairney A. Clinical usefulness of biochemical resorption markers in osteoporosis. Ann Chin Biochem 1999;36:483–91.
  • Masatomi C, Imai K, Wang DH, Ikeda S, Taketa K, Takata K, et al. Urinary excretion of type I collagen cross-linked N-telopeptides, bone mass and related lifestyle in middle-aged women. Acta Med Okayama 1999;53:133–40.
  • Schneider DL, Barrett-Connor EL. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med 1997;157:1241–5.
  • Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E. Three-year followup of bone mineral density change in premeno-pausal women with systemic lupus erythematosus. J Ftheumatol 1999;26:310–7.
  • Eriksen EF, Brbten K, Chares P. New markers of bone metabo-lism: clinical use in metabolic bone disease [review]. Eur J Endocrinol 1995;132:244–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.